title: Proteoglycans and osteolysis.
abstract: Osteolysis is a complex mechanism resulting from an exacerbated activity of osteoclasts associated or not with a dysregulation of osteoblast metabolism leading to bone loss. This bone defect is not compensated by bone apposition or by apposition of bone matrix with poor mechanical quality. Osteolytic process is regulated by mechanical constraints, by polypeptides including cytokines and hormones, and by extracellular matrix components such as proteoglycans (PGs) and glycosaminoglycans (GAGs). Several studies revealed that GAGs may influence osteoclastogenesis, but data are very controversial: some studies showed a repressive effect of GAGs on osteoclastic differentiation, whereas others described a stimulatory effect. The controversy also affects osteoblasts which appear sometimes inhibited by polysaccharides and sometimes stimulated by these compounds. Furthermore, long-term treatment with heparin leads to the development of osteoporosis fueling the controversy. After a brief description of the principal osteoclastogenesis assays, the present chapter summarizes the main data published on the effect of PGs/GAGs on bone cells and their functional incidence on osteolysis.
authors.affiliation: INSERM, UMR 957, Nantes, France.
authors.forename: Marc
authors.initials: M
authors.lastname: Baud'Huin
authors.forename: Céline
authors.initials: C
authors.lastname: Charrier
authors.forename: Gwenola
authors.initials: G
authors.lastname: Bougras
authors.forename: Régis
authors.initials: R
authors.lastname: Brion
authors.forename: Frédéric
authors.initials: F
authors.lastname: Lezot
authors.forename: Marc
authors.initials: M
authors.lastname: Padrines
authors.forename: Dominique
authors.initials: D
authors.lastname: Heymann
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D002460:Cell Line; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010014:Osteolysis / Q000378:metabolism*; D011509:Proteoglycans / Q000378:metabolism*
chemical_list: D011509:Proteoglycans